Imexpharm

Imexpharm EPS

The Earnings per Share (EPS) of Imexpharm (IMP.VN) as of Oct 26, 2026 is 2,267.00 VND. In the previous year, Earnings per Share (EPS) was 2,083.40 VND — a change of 8.81% (higher).

EPS

2,267.00VND

YoY

8.81%

Last updated:

Earnings per Share (EPS) of Imexpharm is 2025 2,267.00 VND. Earnings per Share (EPS) of Imexpharm was 2024 2,083.40 VND. It decreases by 8.81% higher compared to the previous year.

The Imexpharm EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2020
3,145.22 VND
Jan 1, 2021
2,836.21 VND
Jan 1, 2022
3,352.86 VND
Jan 1, 2023
4,279.09 VND
Jan 1, 2024
2,083.40 VND
Jan 1, 2025
2,267.00 VND
Jan 1, 2026 (e)
2,527.36 VND
Jan 1, 2027 (e)
2,930.01 VND
The Imexpharm EPS history
YEAREPSYoY
est2,930.01VND+15.93%
est2,527.36VND+11.48%
2,267.00VND+8.81%
2,083.40VND-51.31%
4,279.09VND+27.63%
3,352.86VND+18.22%
2,836.21VND-9.82%
3,145.22VND+26.27%
2,490.93VND+31.08%
1,900.31VND+14.39%
1,661.25VND-7.33%
1,792.70VND+13.33%
1,581.85VND-38.65%
2,578.21VND+40.34%
1,837.09VND-26.62%
2,503.68VND+3.24%
2,425.19VND-12.60%
2,774.69VND+22.46%
2,265.76VND+12.77%
2,009.17VND-15.24%
2,370.35VND+34.56%
1,761.50VND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

Earnings per Share (EPS) of Imexpharm is 2,267.00 VND in 2025.

Earnings per Share (EPS) of Imexpharm changed from 2,083.40 VND to 2,267.00 VND, representing a 8.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Imexpharm since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Imexpharm

All Key Metrics — Imexpharm